David Michael

David Michael is Managing Partner at Anzu Partners, where he co-leads the firm’s life sciences investments. He has helped develop and financed a portfolio of innovative life sciences companies, including BioSkryb, Inc (single cell genomics), InterVenn (glycoproteomics), and TeraPore Technologies (advanced bioseparations).

Prior to his work at Anzu, Mr. Michael spent 24 years at The Boston Consulting Group, where he was a Senior Partner and served in numerous leadership roles, working in the firm’s offices in Silicon Valley, Hong Kong, and Beijing. Mr. Michael has a B.A. in economics from Harvard and an MBA from Stanford.